Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials-Reference-Cited by-同舟云学术

Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials

Published:2018-05-22 Issue:5 Volume:7 Page:e106
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:JMIR Res Protoc

Author:

Pfirrmann Daniel^ORCID,Haller Nils^ORCID,Huber Yvonne^ORCID,Jung Patrick^ORCID,Lieb Klaus^ORCID,Gockel Ines^ORCID,Poplawska Krystyna^ORCID,Schattenberg Jörn Markus^ORCID,Simon Perikles^ORCID

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference64 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Cancer Survivors: A Booming Population

3. A Web-based self-management exercise and diet intervention for breast cancer survivors: Pilot randomized controlled trial

4. The increasing burden of depression

5. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remote Exercise Training Intervention During the COVID-19 Pandemic: Randomized Controlled Trial;Journal of Medical Internet Research;2024-08-08

2. Multimodal web-based telerehabilitation for patients with post COVID-19 condition (Mainz PCC TeR Study): Study protocol of a randomized controlled clinical trial (Preprint);2024-08-02

3. Remote exercise training during COVID-19 pandemic-induced lockdown is feasible, stabilizes aerobic capacity, and alleviates depressive symptoms: A Randomized Controlled Trial (Preprint);2023-09-27

4. Use of new technologies for the promotion of physical activity in patients with mental illness: A systematic review;World Journal of Psychiatry;2023-04-19

5. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease;Clinical and Translational Gastroenterology;2023-03-01